James N. Ingle

Also affiliated with WinnMed, Mayo Clinic in Arizona

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 7%percentile

0.104Author DataRank

Indexed papers

3in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Lessons learned from a candidate gene study investigating aromatase inhibitor treatment outcome in breast cancer

npj Breast Cancer(2025)10.1038/s41523-025-00733-y

Top 78%

0.104DataRank

Top 78%1 citations

Stefan Winter, Wing‐Yee Lo, Kyriaki Michailidou, Manjeet K. Bolla, Renske Keeman +69 more

Papers

Driven by 31 papers — median percentile 0. Top paper: “Adjuvant Endocrine Therapy in Premenopausal Breast Cancer: 12-Year Results From SOFT”.

Adjuvant Endocrine Therapy in Premenopausal Breast Cancer: 12-Year Results From SOFT

Journal of Clinical Oncology(2022)10.1200/jco.22.01065

N/A

2.2DataRank · unranked

59 citations

Gini F. Fleming, István Láng, Eva Ciruelos, Hervé Bonnefoi, Meritxell Bellet +22 more

Anastrozole has an Association between Degree of Estrogen Suppression and Outcomes in Early Breast Cancer and is a Ligand for Estrogen Receptor α

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-3091

N/A

1.4DataRank · unranked

41 citations

Junmei Cairns, Vera J. Suman, Lois E. Shepherd, Peter A. Fasching, Tanya L. Hoskin +19 more

Evaluation of Alisertib Alone or Combined With Fulvestrant in Patients With Endocrine-Resistant Advanced Breast Cancer

JAMA Oncology(2023)10.1001/jamaoncol.2022.7949

N/A

1.4DataRank · unranked

52 citations

Vera J. Suman, Antonino B. D’Assoro, Jodi M. Carter, Karthik V. Giridhar, Brendan P. McMenomy +18 more

Distinct spatial immune microlandscapes are independently associated with outcomes in triple-negative breast cancer

Nature Communications(2023)10.1038/s41467-023-37806-0

N/A

1.4DataRank · unranked

44 citations

Saranya Chumsri, Douglas Hinerfeld, Yaohua Ma, Xue Wang, David Zahrieh +21 more

Pharmacogenomics of aromatase inhibitors in postmenopausal breast cancer and additional mechanisms of anastrozole action

JCI Insight(2020)10.1172/jci.insight.137571

N/A

1.3DataRank · unranked

45 citations

James N. Ingle, Tanda M. Dudenkov, Krishna R. Kalari, Erin E. Carlson, Jie Na +12 more

Luminal androgen receptor breast cancer subtype and investigation of the microenvironment and neoadjuvant chemotherapy response

NAR Cancer(2022)10.1093/narcan/zcac018

N/A

1.3DataRank · unranked

44 citations

Roberto A. Leon‐Ferre, Jason P. Sinnwell, David Zahrieh, Vera J. Suman, Filho Otto Metzger +15 more

Antitumor activity of Z-endoxifen in aromatase inhibitor-sensitive and aromatase inhibitor-resistant estrogen receptor-positive breast cancer

Breast Cancer Research(2020)10.1186/s13058-020-01286-7

N/A

0.727DataRank · unranked

21 citations

Xiaonan Hou, Mary J. Kuffel, Vera J. Suman, Tanya L. Hoskin, Kathryn E. Reinicke +17 more

Estrogen receptor beta repurposes EZH2 to suppress oncogenic NFκB/p65 signaling in triple negative breast cancer

npj Breast Cancer(2022)10.1038/s41523-022-00387-0

N/A

0.714DataRank · unranked

19 citations

Jodi M. Carter, Tanya L. Hoskin, Vera J. Suman, Malayannan Subramaniam, Michael J. Emch +22 more

Anastrozole Dose Escalation for Optimal Estrogen Suppression in Postmenopausal Early-Stage Breast Cancer: A Prospective Trial

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-0341

N/A

0.303DataRank · unranked

4 citations

Vera J. Suman, Karthik V. Giridhar, Kostandinos Sideras, Donald W. Northfelt, Brenda Ernst +15 more

Blockade of tumor cell-intrinsic PD-L1 signaling enhances AURKA-targeted therapy in triple negative breast cancer

Frontiers in Oncology(2024)10.3389/fonc.2024.1384277

N/A

0.269DataRank · unranked

5 citations

Minzhi Zhang, Mohammad Jalalirad, Roberto Leon Ferre, Royal Shrestha, Tufia C. Haddad +12 more

Role of intratumoral NK cells in triple-negative breast cancer in the FinXX trial and Mayo Clinic cohort.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.510

N/A

0.165DataRank · unranked

2 citations

Jodi M. Carter, Yaohua Ma, Douglas Hinerfeld, Heather Ann Brauer, Sarah Warren +15 more

CHFR expression and sensitivity of breast cancer cells to antimitotic agents in vitro and in the I-SPY trial

npj Breast Cancer(2025)10.1038/s41523-025-00830-y

N/A

0.104DataRank · unranked

1 citations

Karen S. Flatten, Taylor M. Weiskittel, Annapoorna Venkatachalam, Annabella R. Strathman, Olivia K. Rossman +17 more

Lessons learned from a candidate gene study investigating aromatase inhibitor treatment outcome in breast cancer

npj Breast Cancer(2025)10.1038/s41523-025-00733-y

Top 78%

0.104DataRank

Top 78%1 citations

Stefan Winter, Wing‐Yee Lo, Kyriaki Michailidou, Manjeet K. Bolla, Renske Keeman +69 more

Automated mitotic spindle hotspot counts are highly associated with clinical outcomes in systemically untreated early-stage triple-negative breast cancer

npj Breast Cancer(2024)10.1038/s41523-024-00629-3

N/A

0.104DataRank · unranked

1 citations

Jodi M. Carter, David M. Zahrieh, Jason P. Sinnwell, Roberto Salgado, Vera J. Suman +10 more

Data from Anastrozole Regulates Fatty Acid Synthase in Breast Cancer

(2023)10.1158/1535-7163.c.6543547

N/A

0.104DataRank · unranked

1 citations

James N. Ingle, Krishna R. Kalari, Matthew P. Goetz, Richard M. Weinshilboum, Huanyao Gao +4 more

Association Between 21-Gene Assay Recurrence Score and Locoregional Recurrence Rates in Patients With Node-Positive Breast Cancer

JAMA Oncology(2020)10.1001/jamaoncol.2019.5559

N/A

0DataRank · unranked

78 citations

William E. Barlow, Reshma Jagsi, Thomas A. Buchholz, Steven Shak, Frederick L. Baehner +13 more

Interferon signaling and outcomes in triple-negative breast cancer (TNBC) in FinXX, CALGB 40603 (Alliance) and real-world clinico-genomic data.

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.16_suppl.569

N/A

0DataRank · unranked

0 citations

Yi Liu, Sachin Kumar Deshmukh, Jodi M. Carter, Heikki Joensuu, Roberto A. Leon‐Ferre +15 more

Competing risks of death in women treated with adjuvant aromatase inhibitors for early breast cancer on NCIC CTG MA.27

UNC Libraries(2020)10.17615/k0er-5480

N/A

0DataRank · unranked

0 citations

Lois E. Shepherd, Hyman B. Muss, James N. Ingle, Judith‐Anne W. Chapman, Catherine Elliott +4 more

p53 Expression in Node-Positive Breast Cancer Patients: Results from the Cancer and Leukemia Group B 9344 Trial (159905)

UNC Libraries(2020)10.17615/n42e-6c96

N/A

0DataRank · unranked

0 citations

Lynn G. Dressler, Donald A. Berry, Lori J. Goldstein, Gloria Broadwater, Susan M. Edgerton +12 more

Aurora-A kinase oncogenic signaling mediates TGF-β-induced triple-negative breast cancer plasticity and chemoresistance

Oncogene(2021)10.1038/s41388-021-01711-x

N/A

0DataRank · unranked

103 citations

Tufia C. Haddad, Jeffrey L. Salisbury, Derek C. Radisky, Minzhi Zhang, Mark A. Schroeder +16 more

Patient-Derived Xenograft Engraftment and Breast Cancer Outcomes in a Prospective Neoadjuvant Study (BEAUTY)

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-0641

N/A

0DataRank · unranked

20 citations

Vera J. Suman, Jia Yu, Katelyn Santo, Jason P. Sinnwell, Jodi M. Carter +15 more

Development and Characterization of Novel Endoxifen-Resistant Breast Cancer Cell Lines Highlight Numerous Differences from Tamoxifen-Resistant Models

Molecular Cancer Research(2021)10.1158/1541-7786.mcr-20-0872

N/A

0DataRank · unranked

13 citations

Malayannan Subramaniam, Michael J. Emch, Elizabeth S. Bruinsma, James N. Ingle, Matthew P. Goetz +2 more

Anastrozole Regulates Fatty Acid Synthase in Breast Cancer

Molecular Cancer Therapeutics(2021)10.1158/1535-7163.mct-21-0509

N/A

0DataRank · unranked

11 citations

James N. Ingle, Krishna R. Kalari, Matthew P. Goetz, Richard M. Weinshilboum, Huanyao Gao +4 more

Long-term outcomes of patients with node-negative (N0), triple-negative breast cancer (TNBC) who did not receive adjuvant chemotherapy according to stromal TILs (sTILs).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.548

N/A

0DataRank · unranked

0 citations

Jodi M. Carter, David W. Hillman, Kathleen Tenner, David M. Zahrieh, Minetta C. Liu +7 more

Identification of Two Genetic Loci Associated with Leukopenia after Chemotherapy in Patients with Breast Cancer

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-20-4774

N/A

0DataRank · unranked

7 citations

Duan Liu, Steve Scully, James N. Ingle, Paulo C. Lyra, Brigitte Rack +27 more

Genomic characterisation of hormone receptor-positive breast cancer arising in very young women

Annals of Oncology(2023)10.1016/j.annonc.2023.01.009

N/A

0DataRank · unranked

48 citations

Giuseppe Viale, Serena Nik‐Zainal, Peter Savas, Roswitha Kammler, Patrizia Dell’Orto +33 more

Data from Breast Cancer Risk Reduction and Membrane-Bound Catechol O-Methyltransferase Genetic Polymorphisms

(2023)10.1158/0008-5472.c.6497492

N/A

0DataRank · unranked

0 citations

Janet E. Olson, Jianping Zhang, Michelle A.T. Hildebrandt, Liewei Wang, James N. Ingle +15 more

Data from Identification of Two Genetic Loci Associated with Leukopenia after Chemotherapy in Patients with Breast Cancer

(2023)10.1158/1078-0432.c.6531272.v1

Top 100%

0DataRank

Top 100%0 citations

Duan Liu, Steve Scully, James N. Ingle, Paulo C. Lyra, Brigitte Rack +27 more

Data from Identification of Two Genetic Loci Associated with Leukopenia after Chemotherapy in Patients with Breast Cancer

(2023)10.1158/1078-0432.c.6531272

Top 100%

0DataRank

Top 100%0 citations

Duan Liu, Steve Scully, James N. Ingle, Paulo C. Lyra, Brigitte Rack +27 more

Luminal androgen receptor breast cancer subtype and investigation of the microenvironment and neoadjuvant chemotherapy response

UNC Libraries(2025)10.17615/h225-mq92

N/A

0DataRank · unranked

0 citations

Daniel G. Stover, David Zahrieh, Matthew P. Goetz, Eric W. Klee, Lisa A. Carey +15 more

Evaluation of the androgen receptor in patients with ERα-positive early breast cancer treated with adjuvant tamoxifen ± fluoxymesterone

Breast Cancer Research(2025)10.1186/s13058-025-01992-0

N/A

0DataRank · unranked

0 citations

Vera J. Suman, Malvika Solanki, Marie R. Passow, Jordan D. Campbell, Liewei Wang +2 more

James N. Ingle

Indexed papers

Top data-sharing exemplar

Papers